Last reviewed · How we verify

NCT06199817

The Effect Of Multiple Occupational Therapies On Functional Remission And Subjective Recovery For Schizophrenia

Completed NA Last updated 6 February 2024
What this trial tests

NA trial testing occupational therapies in Occupational Therapy in 55 participants. Completed in 19 August 2022.

Timeline
1 June 2016
Primary endpoint
1 May 2022
19 August 2022

Quick facts

Lead sponsorEge University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment55
Start date1 June 2016
Primary completion1 May 2022
Estimated completion19 August 2022

Drugs / interventions tested

Conditions studied

Sponsor

Ege University

Who can join

Adults 18 to 65, any sex, with Occupational Therapy or Schizophrenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: This study aimed to evaluate the effect of multiple occupational therapies on functional remission and subjective recovery of individuals with schizophrenic disorder. Methods: 26 people with schizophrenic disorder were divided into two groups using a random number table. The intervention group participated in routine community mental health center services and a total of 24 sessions of occupational therapies three times a week, while the control group participated in routine community mental health center services.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Occupational Therapy

Currently open trials in the same condition.

Other Ege University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06199817.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing